Question 1

What is the catalog number for Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued?

Accepted Answer

The catalog number for Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued is W1001-01.

Question 2

What sizes are available for Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued?

Accepted Answer

Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued is available in the following size(s): 10 L, 25 L, 50 L.

Question 3

How many pack sizes does Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued come in?

Accepted Answer

Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued is available in 3 different pack sizes.

Question 4

Is Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued in stock?

Accepted Answer

Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 7

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Waymouth’s MB752/1 w/o L-Glutamine (Powder) discontinued

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Mucin 1 / EMA / Episialin / CD227 (HMPV), CF488A conjugate, 0.1mg/mL

MHC II (HLA-DRA) (19-26.1), Biotin conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF647 conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF405S conjugate, 0.1mg/mL

CD47 / IAP (Integrin Associated Protein) (CD47/3019), Biotin conjugate, 0.1mg/mL

Gastrin (GAST/2633), Biotin conjugate, 0.1mg/mL